Sonic Healthcare (OTCMKTS:SKHHY) Hits New 52-Week Low – Should You Sell?

Sonic Healthcare Ltd. Sponsored ADR (OTCMKTS:SKHHY) shares reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $13.00 and last traded at $13.30, with a volume of 50875 shares trading hands. The stock had previously closed at $13.30.

Analysts Set New Price Targets

Several equities analysts recently issued reports on SKHHY shares. Citigroup cut shares of Sonic Healthcare from a “hold” rating to a “strong sell” rating in a research note on Monday, January 26th. Zacks Research upgraded shares of Sonic Healthcare to a “hold” rating in a research report on Friday, April 17th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Reduce”.

Sonic Healthcare Trading Down 0.7%

The stock’s 50-day simple moving average is $14.11 and its two-hundred day simple moving average is $14.92.

Sonic Healthcare Company Profile

Sonic Healthcare (OTCMKTS:SKHHY) is a global provider of medical diagnostics services, specializing in pathology and radiology. Established in 1987 and headquartered in Sydney, Australia, the company has grown into one of the largest laboratory networks in the world. Its ordinary shares trade on the Australian Securities Exchange, and its American Depositary Receipts trade over the counter under the symbol SKHHY.

The company offers a broad range of clinical pathology services, including anatomic pathology, clinical chemistry, hematology, microbiology and molecular diagnostics.